Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
Biotechnology type: 
Biotecnología Roja RED   Biotecnología Azul BLUE   Biotecnología Verde GREEN  Biotecnología Gris GREY  Biotecnología Blanca WHITE  
04/25/2017
ROJA 
Bionaturis out-licenses its Leishmaniasis vaccine for Argentina and Paraguay GRUPO BIONATURIS
Bionaturis has signed an exclusive development, manufacturing, registration, and commercialization license of its Leishmaniasis vaccine with the company Biotandil for Argentina and Paraguay
Bionaturis will receive 50% of the profits resulting of the commercialization.
  View more
12/14/2016
ROJA 
Bionaturis strengthens actions for reducing the use of antibiotics in porcine industry GRUPO BIONATURIS
The biotechnological company takes part in the PROVACIN consortium, joined by partners Piensos Jimenez –leaders of the project- and Iberico Comercializacion (IBERCOM), with the main goal of reducing the use of antibiotics in white and iberian pigs
  View more
05/03/2016
ROJA 
Bionaturis Group grows through the acquisition of the company ZIP Solutions GRUPO BIONATURIS
Zera Intein Protein Solutions (ZIP) is specialized in the development of technologies for the production of peptides and recombinant proteins
Previous to the acquisition, ZIP and a multinational company signed a co-development and a worldwide exclusive license for Splittera®
  View more
01/25/2016
ROJA 
Biobide signs a contract with the U.S. National Institute of Environmental Health Sciences (NIH-NIEHS) GRUPO BIONATURIS
Biobide signs a contract with the U.S. National Institute of Environmental Health Sciences (NIH-NIEHS) This project will analyze the toxicological impact of exposure to 30 chemical compounds using zebrafish as animal model.
The NIEHS is one of the 27 Institutes and Centers composing the US-National Institutes of Health.
  View more
01/12/2016
ROJA 
Bionaturis Group takes part in the development of a vaccine against cervical cancer GRUPO BIONATURIS
Bionaturis Group takes part in the development of a vaccine against cervical cancer The CDTI has granted an incentive of 184.847,40 Euros from the European Programme Eurostars
The project is led by the company BioEnergy GmbH & Consultant with participation from the German Cancer Research Center
  View more
01/12/2016
ROJA 
Bionaturis Group takes part in the BIOMAP project GRUPO BIONATURIS
BIOMAP is a consortium led by Laboratories Rovy that includes Vivacell Biotechnology Spain, Vaxdyn, and Bionaturis
The Feder-Interconecta Programme, via the Centre for the CDTI, has granted Bionaturis 572.988€ for this biomedicine development initiative.
  View more
10/13/2015
ROJA 
Bionaturis unveils the development of six new biotech products GRUPO BIONATURIS
-Five of these new drugs point to Animal Health sector that represents a $100 billion global annual worldwide market
- Bionaturis Group strengthens its position as a reference partner for animal health
  View more
Search